A new class of medications called glucagon-like peptide 1 receptor agonists, or GLP-1s, have surged in popularity by making weight loss easier for patients. The brands — Wegovy and Zepbound for weight loss and Ozempic and Mounjaro for type 2 diabetes — have become household names.
The drugs often quiet “food noise,” or brain chatter about food, and they’ve been shown to have an effect on heart disease and sleep apnea, among other conditions. Users, too, have reported changes in addictive behaviors. However, the drugs can be costly, difficult to find and to have some side effects, such as gastrointestinal issues.
What are your questions about drugs and weight loss? Share your questions with CNN below.